Emerging Infectious Diseases: Strategies for Detecting and Preventing

60

Course Overview

This course is designed to provide an overview of emerging infectious diseases (EIDs), offering useful historical and scientific underpinnings, as well as an introduction to the less obvious consequences of rapidly spreading infections. It is expected that this will empower healthcare professionals to best serve their patients, despite the challenges projected by EID.  

Learning Outcomes 
Upon the completion of this course, the learner should be able to:

  • Identify factors that contribute to the emergence of novel infectious pathogens, including microbial adaptation, changing ecosystems, globalization, human behavior changes, technology advancements, and public health system preparedness gaps.  
  • Interpret epidemiological data and outbreak investigation findings using historical patterns to rapidly characterize transmission dynamics, population susceptibility, spectrum of clinical illness, and evolutionary traits of emerging pathogens.  
  • Identify the clinical presentations and pathological effects associated with recently emerged diseases like Mpox, SARS-CoV-2, Zika, West Nile virus, and avian influenza strains, as well as the diagnostics required to confirm suspected infections.  
  • Identify the implications of antimicrobial resistance to construct interdisciplinary plans of action for treatment and prevention of spread of infection within a healthcare setting given examples of multidrug-resistant pathogens like Candida auris and New Delhi Metallo-Beta-lactamase producing Gram-negative bacteria.  
  • Identify novel methods of detecting and treating emerging infectious diseases including advances in artificial intelligence, strategies to prevent spread of zoonotic diseases, and pharmacological treatments in development of combat pathogens.  
  • Employ evidence-based infection prevention and control strategies tailored to the identified routes of transmission and population susceptibility to contain person-to-person and zoonotic spread within healthcare settings. 
     

About the Author/Presenter 

Geena Kludjian, PharmD, BCIDP, is an infectious diseases clinical pharmacist at Cooper University Hospital. She completed 2 years of pharmacy practice residency with one specialized in infectious diseases. Dr. Kludjian’s interests include emerging infectious diseases, antimicrobial stewardship, resistant Gram-negative bacterial infections, and multidisciplinary approaches to infection prevention.  


Audience/Accreditations and Approvals 
TRC Healthcare/ NetCE 
In support of improving patient care, this activity has been planned and implemented by TRC Healthcare/ NetCE. TRC Healthcare/NetCE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 
This course is designed for the following healthcare professions (select your profession for details): 
Nursing, Pharmacy, Physician

If you require special accommodations, please contact Colibri Healthcare Support by clicking here: Contact Us